Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

Clinical trial NCT04318717 · RECRUITING

Trial details

NCT number: NCT04318717
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mucosal Melanoma of the Head and Neck

Start date: 2020-05-29
Primary completion: 2030-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.